Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Hematologic Neoplasms 2Advanced Malignant Solid Neoplasm 2Urinary Bladder Neoplasms 1Spondylitis, Ankylosing 1Signs and Symptoms 1Rectal Neoplasms 1Psoriasis 1Ovarian Neoplasms 1Neoplasm Metastasis 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Lymphedema 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Inflammatory Bowel Diseases 1Endometrial Neoplasms 1Crohn Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Crohn Disease × Methods × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡